Titan Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Titan Pharmaceuticals, Inc. had Operating Lease Right-of-Use Assets of $32.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-20
- 2024-03-31: Operating Lease, Right-of-Use Asset $32.00K.
- 2023-12-31: Operating Lease, Right-of-Use Asset $63.00K.
- 2023-09-30: Operating Lease, Right-of-Use Asset $94.00K.
- 2023-06-30: Operating Lease, Right-of-Use Asset $124.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-03-31 | $32.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $63.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $94.00K 10-K · filed 2024-04-01 |
| 2023-06-30 | $124.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $154.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $183.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $212.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $241.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $269.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $297.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $324.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $353.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $72.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $141.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $208.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $273.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $336.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $397.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $456.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $514.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $569.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |